Medtronic's Hugo robot clears FDA for general surgery
Medtronic won FDA clearance to use its Hugo robotic-assisted surgery system in general surgery in the U.S., pushing it well past its old urology-only approval. That unlocks a pool of roughly 3.5 million abdominal procedures a year. Now the question is whether Hugo hits its 50,000-procedure target.
- Original source: finance.yahoo.com.
- The source published it on Nov 20, 2026 at 2:13 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
The FDA has cleared Medtronic's Hugo robotic-assisted surgery system for general surgery procedures in the U.S. The authorization widens Hugo's approved use beyond urologic surgery into a broader set of abdominal and soft-tissue operations. General surgery accounts for about 3.5 million procedures a year in the U.S., which significantly expands the robot's potential caseload.
Medtronic comes to this with scale: the medical equipment group carries a market cap of roughly $123.3B and has spent more than 50 years selling open and laparoscopic tools into these same abdominal and soft-tissue procedures. That means Hugo drops into hospital relationships Medtronic already has. The company also points to the robot's modular design and its integration of LigaSure vessel sealing, which has been used in over 45 million procedures, as reasons hospitals that already buy its instruments would find Hugo flexible.
The adoption curve is the real story. Hugo procedures globally are running at more than two times the robotic surgery market and are expected to exceed 50,000 by the end of Medtronic's current fiscal year. Medtronic sits among the large device makers riding growth in surgical and AI-enabled infrastructure.
That 50,000 figure is the marker to watch. Hitting it — or missing it — will show how fast hospitals are actually moving general surgery cases onto Hugo, and how much of that 3.5-million-procedure pool is beginning to convert.
TopicsMedtronic · Hugo · FDA · LigaSure · NYSE:MDT
Source: finance.yahoo.com
Written by AI from verified reporting.
More stories
- Health & science wired.com 1 viewEl Niño Pushes California's Coastal Waters Off the Charts, and the Storms Are Following
- Health & science biobuzz.io 1 viewFDA approves AstraZeneca's once-weekly Klygefa for generalised myasthenia gravis
- Health & science theguardian.com 1 viewPancreatic cancer pill erases tumours in 1 in 12 patients, trial finds
- Health & science pluang.com 1 viewGalleri wins FDA panel nod as GRAIL chases first multi-cancer screening approval

